Implementation and results of a dedicated telemedicine program (TeleTrachea) for patients with tracheal diseases.

<bold>Background:</bold> Central airway diseases require frequent outpatient visits to a specialized medical center, due to tracheal devices. Many of these patients have mobility and cognition restrictions or require specialized transport due to the need for supplemental oxygen. This study describes the implementation and results of a telemedicine program dedicated to patients with central airway diseases based in a Brazilian public health system. <bold>Methods:</bold> A retrospective study of telemedicine consultation for patients with central airway diseases referred to a public academic hospital between August 1, 2020, and August 1, 2022. The consultations occurred in a telemedicine department using the hospital's proprietary platform. Data retrieved consisted of demographics and disease characteristics. The analysis included the savings in kilometers not traveled and the carbon footprint based on reducing CO2 emissions. <bold>Results:</bold> 1153 telemedicine visits conducted in 516 patients (median age of 31.5 years). 290 patients (56.2%) had a tracheal device (129 silicone T-Tube, 128 tracheostomy, and 33 endoprosthesis) and 159 patients (30.8%) had difficulties in transportation to the specialized medical center. Patients were served from 147 Brazilian cities from 22 states. The savings in kilometers traveled was 1.224.108,54km, corresponding to a 250,14-ton reduction in CO2 emissions. <bold>Conclusions:</bold> Telemedicine consultations for patients with central airway diseases are feasible and safe. Cost savings and the possibility of disseminating specialized care make telemedicine a fundamental tool in current medical practice.